silver has been researched along with Rhinitis in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 6 (75.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Krishnan, R; Rotenberg, BW; Scott, JR; Sowerby, LJ | 1 |
Bassiouni, A; Drilling, A; James, C; Rajiv, S; Vreugde, S; Wormald, PJ | 1 |
Al-Asousi, F; Dadgostar, A; Javer, A | 1 |
Xing, L; Zhang, X; Zhao, C; Zhao, X | 1 |
Chen, SY; Chou, HH; Huang, MT; Ou, KL; Pender, SLF; Ruslin, M | 1 |
Goggin, R; Jardeleza, C; Vreugde, S; Wormald, PJ | 1 |
Schlosser, RJ | 1 |
Egli, KL | 1 |
1 review(s) available for silver and Rhinitis
Article | Year |
---|---|
Sinonasal methicillin-resistant Staphylococcus aureus: updates on treatment.
Topics: Administration, Intranasal; Administration, Oral; Anti-Bacterial Agents; Chronic Disease; Female; Honey; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nasal Lavage; Photochemotherapy; Rhinitis; Silver; Sinusitis; Staphylococcal Infections | 2017 |
2 trial(s) available for silver and Rhinitis
Article | Year |
---|---|
The effectiveness of topical colloidal silver in recalcitrant chronic rhinosinusitis: a randomized crossover control trial.
Topics: Administration, Intranasal; Administration, Topical; Adult; Age Factors; Aged; Aged, 80 and over; Chronic Disease; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Rhinitis; Risk Assessment; Severity of Illness Index; Sex Factors; Silver; Sinusitis; Tertiary Care Centers; Treatment Outcome | 2017 |
Benefits of a Nanosilver Nasal Spray for Postoperative Care of Patients with Chronic Rhinosinusitis.
Topics: Chronic Disease; Humans; Nasal Sprays; Postoperative Care; Rhinitis; Silver; Sinusitis | 2020 |
5 other study(ies) available for silver and Rhinitis
Article | Year |
---|---|
Topical colloidal silver as an anti-biofilm agent in a Staphylococcus aureus chronic rhinosinusitis sheep model.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Disease Models, Animal; Rhinitis; Sheep; Silver; Sinusitis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2015 |
The application of silver nano-particles on developing potential treatment for chronic rhinosinusitis: Antibacterial action and cytotoxicity effect on human nasal epithelial cell model.
Topics: Anti-Bacterial Agents; Epithelial Cells; Escherichia coli; Humans; Metal Nanoparticles; Microbial Sensitivity Tests; Rhinitis; Silver; Sinusitis; Staphylococcus aureus | 2017 |
Colloidal silver: a novel treatment for Staphylococcus aureus biofilms?
Topics: Anti-Bacterial Agents; Biofilms; Biomass; Chronic Disease; Colloids; Complementary Therapies; Drug Dosage Calculations; Humans; Microscopy, Confocal; Rhinitis; Silver; Sinusitis; Staphylococcal Infections; Staphylococcus aureus | 2014 |
The pathophysiology of chronic rhinosinusitis.
Topics: Biofilms; Chronic Disease; Genetic Predisposition to Disease; Humans; International Cooperation; Minimally Invasive Surgical Procedures; Polymorphism, Genetic; Rhinitis; Rhinoplasty; Silver; Sinusitis; Staphylococcal Infections; Staphylococcus aureus; Taste; Vitamin D | 2014 |
Argyria: consequences of using an antiquated medication.
Topics: Argyria; Female; Humans; Middle Aged; Rhinitis; Silver | 2000 |